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Introduction

42
Pregnancy is characterized by extensive metabolic alterations in carbohydrate, fat and protein 43 metabolism to ensure adequate fetal growth and to meet the increased physiological demands 44 of pregnancy, including the additional energy stores required for labor and lactation.
45
Maternal glycemic control depends on the balance between pancreatic β-cell secretion of 46 insulin, insulin clearance, and insulin action in liver, muscle and adipose tissue [1, 2] . Insulin 47 sensitivity changes considerably during pregnancy and declines progressively in late gestation 48 [1, 3] . The fetoplacental unit has been implicated as a major source of maternal insulin 49 resistance, which is rapidly reversed upon delivery [4] . Inadequate β-cell responsiveness add 50 to the increased insulin resistance and leads to gestational diabetes mellitus which is 51 associated with risk of type 2 diabetes mellitus (T2DM) [3, 5] .
52
Several risk factors correlate highly with gestational diabetes, including advanced maternal 53 age, fetal macrosomia in a previous pregnancy, obesity, and a family history of diabetes [6] . 54 However, early pregnancy screening to identify women at risk for gestational diabetes [2, 7] 55 or postpartum T2DM [3, 5] has not been successful.
56
Metabolomics studies-comprehensive analysis of low-molecular-weight metabolites-have 57 shown great promise in identifying novel pathways and early biomarkers of insulin resistance 58 and T2DM [8, 9] . Several putative metabolic markers and pathways associated with insulin 59 resistance and T2DM have been identified and validated, such as increased levels of 60 branched-chain amino acids (BCAA) and related metabolites [10, 11] . Only a few studies 61 have examined the metabolomics of hyperglycemia or gestational diabetes during pregnancy; 62 however, the findings suggest that T2DM and gestational diabetes share similar features and 63 that their metabolic signatures might partly overlap [12] [13] [14] [15] To study the postpartum metabolic transition, we included subjects that were sampled both 77 during their third trimester (gestational week 32 ± 4) and postpartum (11 ± 3 months 78 postpartum). Eleven women had gestational diabetes mellitus (GDM group), 24 had normal 79 glucose tolerance (NGT group) and 21 were normoglycemic but at increased risk of GDM
80
(NGT risk group) (Figure 1 ). The distribution of risk factors for GDM in the three groups is 81 shown in Table 1 .
82
For the GDM group, we recruited pregnant women diagnosed with GDM at Sahlgrenska 
Sample Preparation and Metabolomics Analysis
118
The run order and sample preparation were designed to minimize biases from sample 
Data Processing
132
To quantify and identify metabolites, we used an in-house MATLAB script. Putative Table 2 . BMI during pregnancy was higher in the NGT-risk and GDM groups than 167 in the NGT group (P < 0.01). Gestational weight gain was lowest in the GDM group (P < 168 0.05 versus NGT-risk). Insulin resistance (HOMA-IR) was higher in the NGT-risk group than 169 in the NGT group (P < 0.01), and insulin sensitivity (revised QUICKI) was lowest in the 170 GDM group (P < 0.05 vs NGT). Postpartum, the NGT-risk and GDM groups still had 171 significantly higher BMIs and higher waist-to-height ratios than the NGT group.
172
The postpartum shift in clinical measurements is shown in Figure 2 . In the NGT group, NGT-risk and GDM groups in Supplemental Table S1 . (Table S1 ). The predictability of the OPLS models
198
(i.e., the percent of the total variation predicted by the calculated latent variable/OPLS 199 component, Q2) was >75%, and two significant components, one predictive and one Postpartum, asymmetric dimethylarginine and citrulline levels increased significantly in the 211 GDM and NGT-risk groups but not in the NGT group (P > 0.27), and the level of Table S1 . 
243
In women with postpartum GDM, increased levels of BCAAs, or other mitotoxic/lipotoxic 244 metabolites from these amino acids, might increase risk for T2DM through their negative 245 effects on β-cell function [31] . Insulin resistance can also be influenced by BCAA (Table S1 ).
254
We also found significant postpartum alterations in several other interesting amino acids. For 
